Orofer FCM 1K Injection

Regulated Product — Business License Required

B2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.

Product photography not yet supplied — this space will show official packaging imagery once provided by the business.

Product Overview

Orofer FCM 1K Injection is an iron replacement medicine containing ferric carboxymaltose. Its labelling describes it for the treatment of anaemia caused by insufficient iron in the body, where the number of red blood cells drops. Iron is required to make red blood cells, which carry oxygen throughout the body. It is described as replenishing the iron lost from the body, supporting the formation of new red blood cells and haemoglobin.

Active ingredient
Ferric carboxymaltose
Strength
1000 mg (1K)
Dosage form
Solution for injection / infusion
Therapeutic class
Parenteral iron replacement (anti-anaemic)
Regulatory status
Prescription / regulated — confirmed per enquiry and destination market
Availability
Confirmed per enquiry

Product Information

The following description reflects information associated with this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.

Described Uses

  • Described for the treatment of iron deficiency anaemia
  • Described for the treatment of anaemia due to chronic kidney disease
  • Described as replenishing body iron to support red blood cell and haemoglobin formation
Note: SDO Pharma has not independently verified the manufacturer’s efficacy claims for this product and makes no additional medical or clinical claims beyond what is described here. We do not claim FDA, UAE, EU, or other specific regulatory approval for this product unless independently verified. This is a prescription / regulated-status product; patient dispensing is the responsibility of the licensed business customer, not SDO Pharma.

Described Dosage & Administration

  • Used only if prescribed by the doctor
  • Administered by a healthcare provider
  • The doctor determines the dosage according to the patient’s health requirements

Described Side Effects

Commonly described side effects include:

  • Injection site reactions (pain, swelling, redness)
  • Nausea and vomiting
  • Dark coloured stool
  • Headache
  • Dizziness
  • High blood pressure

These are described as commonly temporary. Any severe, persistent, or unexpected reaction requires prompt medical attention.

Precautions

  • Pregnant mothers should use it only if prescribed by the doctor; described as safe for breastfeeding mothers if advised by the doctor
  • Described as not affecting the ability to drive
  • Used with caution in patients with kidney problems, and considered safe for kidney patients only if advised by the doctor

This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.

B2B, Import & Export

B2B, Import & Export Enquiries

SDO Pharma supports business enquiries for pharmaceutical and healthcare products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.

We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.

Product Enquiry

Request Product Information

Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.

Frequently Asked Questions

Per its labelling it contains ferric carboxymaltose and is used for iron deficiency anaemia and anaemia due to chronic kidney disease. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.

Its labelling describes it as administered by a healthcare provider only if prescribed, with the doctor determining the dosage according to the patient’s requirements.

Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.

Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.

Explore More

Related Product Categories

SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.

View Products & Services